Quantum BioPharma Ltd C.QNTM

Here are the reason for the circular:

[Mhae88]

First of all is that, under Bokhari's headship, he and his board member failed to address the dramatic loss of Shareholder value, with the Class B Shares trading over 97% lower than when Dr. Bokhari was appointed Interim Chief Executive Officer;

[Mhae88]

massively diluted Shareholder interests by issuing almost 16 million Class B Shares at low prices, increasing the number outstanding by over 83% in just seven weeks

[Mhae88]

awarded over $5.7 million of bonus Share compensation to Dr. Bokhari in February 2021 for services yet to be provided and close to $1 million in Shares and/or cash to the other directors (Stephen Buyer, Robert Ciaruffoli, James Datin, Gerald Goldberg and Larry Kaiser), the latter amount being almost twice the previous year’s compensation;

[Mhae88]

caused FSD to reimburse Dr. Bokhari’s privately owned and controlled company for over $1.4 million of expenses in 2020, with limited transparency or explanation;

[Mhae88]

failed to effectively implement the Company’s business plan to become a pharmaceutical and biotechnology company, having to date failed to meet any of their modest stated goals

[Mhae88]

denied Shareholders any say on the change of the Company’s strategic focus, failing to hold a Shareholders’ meeting in 2020 and seeking to delay holding a meeting in 2021

[Mhae88]

taken retaliatory actions against Concerned Shareholders that have unnecessarily exposed FSD to liability

[Mhae88]

All of the things that has been said are the things that Bokhari failed to do. We can see that all of those affected the company.